• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [983 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2023 Canary Health Service [Genicular artery embolization for the treatment of knee osteoarthritis]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: acute exacerbation of chronic obstructive pulmonary disease -diagnostic approach, optimal use of treatments, and follow-up]
2023 Center for Drug Evaluation (CDE) [Assessment of the optimal implementation strategy for pneumococcal vaccination policies in groups at high risk of invasive pneumococcal disease]
2023 Canary Health Service [Clinical effectiveness and cost-effectiveness of the extension of colorectal cancer screening up to 74 years of age in general population]
2023 Canary Health Service [Effectiveness, safety and cost-effectiveness of real time continuous glucose monitoring systems, open-loop systems and hybrid closed-loop systems (artificial pancreas) for patients with diabetes]
2023 Canary Health Service [Cost-effectiveness of systematic vaccination against invasive meningococcal disease due to serogroup B in childhood]
2023 Canary Health Service [Determination by chemiluminescence of autoantibodies to domain 1 of beta 2 glycoprotein I in patients with antiphospholipid syndrome]
2023 Canary Health Service [Cost-effectiveness of childhood vaccination against invasive meningococcal disease due to ACWY serogroups]
2023 Health Information and Quality Authority (HIQA) Repatriation of paediatric haematopoietic stem cell transplant services to Ireland: a Health Technology Assessment
2023 NIHR Health Technology Assessment programme Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies
2023 Basque Office for Health Technology Assessment (OSTEBA) [Massive parallel sequencing for the diagnosis of acute leukaemia]
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: rapid assessment zones in emergency departments - organizational characteristics and their impact]
2023 NIHR Health Services and Delivery Research programme Factors which facilitate or impede patient engagement with pulmonary and cardiac rehabilitation: a rapid evaluation mapping review
2023 NIHR Health Services and Delivery Research programme A multimethod study of NHS 111 online
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: continuum of care and services for individuals with a traumatic spinal cord injury in Québec - characteristics, care pathways and clinical outcomes for adults from 2014 to 2020]
2023 NIHR Health Services and Delivery Research programme Thinking ahead about medical treatments in advanced illness: a qualitative study of barriers and enablers in end-of-life care planning with patients and families from ethnically diverse backgrounds
2023 NIHR Health Services and Delivery Research programme Towards achieving interorganisational collaboration between health-care providers: a realist evidence synthesis
2023 NIHR Health Services and Delivery Research programme Youth violence intervention programme for vulnerable young people attending emergency departments in London: a rapid evaluation
2023 Malaysian Health Technology Assessment (MaHTAS) Bio-electrical impedance analysis for the assessment of sarcopenia in elderly
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: implantable medical device tracking methods]
2023 NIHR Health Technology Assessment programme Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
2023 Malaysian Health Technology Assessment (MaHTAS) Human skin allograft for burns
2023 Malaysian Health Technology Assessment (MaHTAS) Negative pressure wound therapy
2023 Health Information and Quality Authority (HIQA) Expansion of the childhood immunisation schedule to include varicella (chickenpox) vaccination: health technology assessment
2023 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: optical genome mapping - diagnosis and prognostic stratification of hematological malignancies]
2023 WorkSafeBC Causal association between carpal tunnel release surgery and trigger finger
2023 WorkSafeBC Esketamine as treatment for depression and PTSD
2023 WorkSafeBC Migraines and the (Moderna) COVID-19 vaccine
2023 WorkSafeBC Causal association between COVID-19 infection and irritable larynx syndrome
2023 WorkSafeBC Flotation therapy as treatment for concussions
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: service trajectories and services for at risk or neglected children and their families]
2022 Center for Drug Evaluation (CDE) The reimbursement coverage decisions and pricing rules for medical devices in Taiwan
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Optical coherence tomography angiography in vascular eye diseases]
2022 NIHR Health Technology Assessment programme Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 1 - overview of heart and lung transplantation in Québec]
2022 Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous transvascular implantation of a coronary sinus reducing stent. Update 2022
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 3 - overview of renal and pancreatic transplantation in Québec]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: chronic obstructive pulmonary disease- detection, diagnosis, optimal use of medications and inhalation devices, and global management]
2022 Belgian Health Care Knowledge Centre (KCE) Evaluation of Shingrix vaccine against herpes zoster
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Cardiac monitoring with textile wearable Holter for atrial fibrillation detection after cryptogenic stroke]
2022 WorkSafeBC N-acetylcysteine (NAC) as treatment for complex regional pain syndrome (CRPS): 2022 Update
2022 WorkSafeBC Balloon spacer as treatment for massive rotator cuff tear
2022 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Efficacy and safety of transanal irrigation in adults with bowel dysfunction]
2022 Adelaide Health Technology Assessment (AHTA) Small gene panel testing for non-small cell lung carcinoma
2022 Adelaide Health Technology Assessment (AHTA) Whole genome sequencing of antimicrobial-resistant pathogens
2022 Malaysian Health Technology Assessment (MaHTAS) Immunotherapy for PD-L1 positive advanced non-small cell lung cancer
2022 NIHR Health Technology Assessment programme Moulded cast compared with K-wire fixation after manipulation of an acute dorsally displaced distal radius fracture: the DRAFFT 2 RCT
2022 Malaysian Health Technology Assessment (MaHTAS) Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for non-small cell lung cancer
2022 WorkSafeBC Dupuytren's contracture and wrist fractures
2022 WorkSafeBC Ketamine infusion therapy for hyperalgesia and or central sensitivity pain
2022 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Conductive intravesical chemohyperthermia with mitomycin in non-muscle invasive bladder cancer: review of guidelines and ongoing research]
2022 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Assessment and clinical management of self-harm in adolescence: evidence-based protocol]
2022 The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Delamanid (repeal of the exemption: pulmonary multi-drug resistant tuberculosis, ≥ 10 kg)]
2022 Malaysian Health Technology Assessment (MaHTAS) Early cancer detection test for lung (EarlyCDT-Lung)
2022 WorkSafeBC Vision therapy as treatment for traumatic brain injury: 2022 update
2022 NIHR Health Services and Delivery Research programme Safety of disinvestment in mid- to late-term follow-up post primary hip and knee replacement: the UK SAFE evidence synthesis and recommendations
2022 WorkSafeBC Inpatient versus outpatient programs as treatment for PTSD
2022 WorkSafeBC Oral collagen supplements for shoulder sprain strain
2022 Malaysian Health Technology Assessment (MaHTAS) First line targeted therapy for advanced hepatocellular carcinoma (aHCC)
2022 WorkSafeBC Lose-dose naltrexone as treatment for post-COVID conditions
2022 Basque Office for Health Technology Assessment (OSTEBA) [Autism spectrum disorder: scientific evidence on its detection, diagnosis and treatment]
2022 Malaysian Health Technology Assessment (MaHTAS) Transcutaneous oxygen pressure monitoring (TcPO2)
2022 Malaysian Health Technology Assessment (MaHTAS) Sublingual immunotherapy (SLIT) for atopy (allergic rhinitis, eczema and asthma)
2022 Malaysian Health Technology Assessment (MaHTAS) Mesenchymal stem cells for retinitis pigmentosa and other degenerative retina disease
2022 WorkSafeBC Efficacy and/or effectiveness of treatments for lateral epicondylitis - barbotage and ultrasonic tenotomy
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: solid organ transplantation – Section 2 - overview of liver transplantation in Québec]
2022 Health Sciences Institute in Aragon (IACS) [Digital dermatoscopy]
2022 Swiss Federal Office of Public Health (FOPH) Thyroid function tests for the diagnosis of suspected primary or secondary thyroid dysfunction
2022 NIHR Public Health Research (PHR) programme E-health interventions targeting STIs, sexual risk, substance use and mental health among men who have sex with men: four systematic reviews
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: a look at Québec’s family medicine groups and a proposal to segment the population to support continuous quality improvement approaches based on health needs]
2022 Swiss Federal Office of Public Health (FOPH) Levothyroxine for patients diagnosed with subclinical hypothyroidism
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: organization of care and services for the prevention and management of post COVID-19 conditions]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: helicopter emergency medical services (HEMS) - needs analysis and clientele identification]
2022 The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Migalastat (new therapeutic indication: Fabry disease, 12 to < 16 years)]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: updated recommendations for adjusting antidiabetic medication in type 2 diabetes]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: evaluation of the relevance of newborn screening for severe combined immunodeficiency SCID]
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: relevance of the prerequisite of the use of an immunosuppressant drug for the coverage of biologic agents (gastroenterology and dermatology)]
2022 NIHR Health Services and Delivery Research programme Assessment and management pathways of older adults with mild cognitive impairment: descriptive review and critical interpretive synthesis
2022 Health Information and Quality Authority (HIQA) Health technology assessment of metabolic surgery for the treatment of comorbid type 2 diabetes and obesity
2022 NIHR Health Technology Assessment programme One-session treatment compared with multisession CBT in children aged 7–16 years with specific phobias: the ASPECT non-inferiority RCT
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Sialendoscopy for obstructive salivary gland disease]
2022 Austrian Institute for Health Technology Assessment (AIHTA) Long COVID care pathways and structures: an updated scoping review
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Casirivimab and imdevimab to treat Covid-19 in patients negative for the Omicron genotype]
2021 Austrian Institute for Health Technology Assessment (AIHTA) Long COVID care pathways: a systematic review
2021 Center for Drug Evaluation (CDE) Real-world results of immune checkpoint inhibitors from the Taiwan National Health Insurance Registration System
2021 WorkSafeBC Acupuncture or massage therapy as treatment for occipital neuralgia
2021 Andalusian Health Technology Assessment Area (AETSA) [18F-FDG in myocardial viability for revascularization]
2021 Andalusian Health Technology Assessment Area (AETSA) [Clinical utility of optical coherence tomography angiography in exudative age-related macular degeneration management]
2021 NIHR Health Services and Delivery Research programme Hospital-based specialist palliative care compared with usual care for adults with advanced illness and their caregivers: a systematic review
2021 NIHR Health Technology Assessment programme Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model
2021 Andalusian Health Technology Assessment Area (AETSA) [High intensity focused ultrasound (HIFU) in organ-confined prostate tumors]
2021 Malaysian Health Technology Assessment (MaHTAS) Targeted therapies in combination with neoadjuvant chemotherapy for HER2-positive breast cancer and economic evaluation
2021 Malaysian Health Technology Assessment (MaHTAS) Therapeutic drug monitoring (TDM) for anti-tuberculosis
2021 Malaysian Health Technology Assessment (MaHTAS) Mobile C-arm fluoroscopy for cardiothoracic surgery
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: assessment of the relevance of newborn screening for spinal muscular atrophy]
2021 Swiss Federal Office of Public Health (FOPH) Effectiveness and safety of vitamin B12 tests
2021 Malaysian Health Technology Assessment (MaHTAS) Viscoelastic haemostatic assay for non-cardiac surgery
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: organization of care and services related to alternate levels of care (ALC)]
2021 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Sentinel lymph node biopsy in oral cavity carcinoma: clinical effectiveness, safety, and cost-effectiveness]
2021 The Regional Health Technology Assessment Centre (HTA-centrum) Efficacy and safety of endovascular versus surgical arteriovenous fistula creation for hemodialysis